# Effects of a Combined Dietary and Physical Activity Intervention on Bone Density, Lean Mass and Fat Mass in Adults: The GOTO Trial

**Authors:** F. A. Bogaards, Inge Groenendijk, Thies Gehrmann, Marian Beekman, Nico Lakenberg, H. Eka D. Suchiman, Lisette C. P. G. M. de Groot, Marcel J. T. Reinders, P. Eline Slagboom

PMC · DOI: 10.1002/jcsm.70226 · Journal of Cachexia, Sarcopenia and Muscle · 2026-03-08

## TL;DR

A combined diet and exercise program improved bone density in men while reducing fat and lean mass, without harming bone health when paired with physical activity.

## Contribution

This study demonstrates that combining diet and exercise can improve bone density in non-obese adults, particularly in males with good baseline bone health.

## Key findings

- Males showed a 3.0% increase in lumbar spine bone mineral density (BMD) after the intervention.
- Lean mass decreased by 1.4 kg in males and 1.1 kg in females, while fat mass decreased by 1.5% in both genders.
- Improved BMD in males was associated with weight loss, reduced fat percentage, and better immune-metabolic health.

## Abstract

Nutritional weight‐loss interventions are known to reduce bone mineral density (BMD), which can be prevented by adding (resistance) exercise training. However, this combined effect is not well studied in non‐obese adults. In addition, the association between biomarkers and metabolite‐based composite health markers with changes in BMD in such an intervention has not been studied as thoroughly.

The aims of the current study were to investigate the effect of a combined nutritional and activity lifestyle intervention on lumbar spine and total body BMD in healthy middle‐aged to older adults, and to relate these effects to a selection of immune‐metabolic biomarkers, muscle mass and fat mass measurements, and two composite metabolite‐based health scores.

In this ancillary study of the single‐arm Growing Old TOgether (GOTO) trial (trial registration number GOTNL3301 [https://onderzoekmetmensen.nl/nl/trial/27183], NL‐OMON27183), 134 participants (mean age 62.9 years, 49% female) undertook a 13‐week lifestyle modification, incorporating 12.5% caloric restriction and 12.5% increase in physical activity. The impact on lumbar spine and total body BMD was evaluated using dual‐energy X‐ray absorptiometry (DEXA). The intervention effect on BMD was related to changes in immune‐metabolic biomarkers and two metabolite‐based immune‐metabolic health scores.

The trial significantly reduced bodyweight with 3.3 and 3.4 kg, consisting of 1.4 and 1.1 kg lean mass, in males (fdr < 0.001) and females (fdr < 0.001), respectively. Lean mass reduced by 1.4 kg in males (fdr < 0.001) and 1.1 kg in females (fdr < 0.001), whereas total body fat% reduced significantly with −1.5% (fdr < 0.001) in males and −1.5% (fdr < 0.001) in females. In males, lumbar spine BMD increased with 3.0% (fdr < 0.001) and total body BMD with 0.7% (fdr = 0.002). In females, the lumbar spine BMD had a trend in the upwards direction (1.2%, fdr = 0.09) and the total body BMD remained stable (0.4%, fdr = 0.07). In males, the increase in lumbar spine BMD was significantly associated with decreased weight (fdr = 0.001) and with decreased body and trunk fat% (fdr = 0.001, fdr = 0.001) and improved immune‐metabolic health (fdr = 0.02). Males with higher BMD but a poor metabolite‐based health score at baseline had a stronger increase in lumbar spine BMD (fdr = 0.03).

A combined nutritional and activity lifestyle intervention significantly improved BMD of males with good bone health at baseline while at the same time improving metabolic health. Nutritional weight‐loss interventions may not harm BMD when combined with exercise.

## Full-text entities

- **Genes:** IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, APOA1 (apolipoprotein A1) [NCBI Gene 335] {aka AMYLD3, HPALP2, apo(a)}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, IGFBP3 (insulin like growth factor binding protein 3) [NCBI Gene 3486] {aka BP-53, IBP-3, IBP3, IGFBP-3}
- **Diseases:** fractures (MESH:D050723), inflammation (MESH:D007249), metabolic syndrome (MESH:D024821), Osteoporotic fractures (MESH:D058866), diabetic (MESH:D003920), overweight (MESH:D050177), BMD (MESH:D001851), obese (MESH:D009765), loss of muscle mass (MESH:C536030), frailty (MESH:D000073496), malnourished (MESH:D044342), Weight loss (MESH:D015431), Osteoporosis (MESH:D010024), mineral (MESH:C537337), type 2 diabetes (MESH:D003924), GOTO (MESH:D016773), cognitive decline (MESH:D003072)
- **Chemicals:** 3-hydroxybutyrate (MESH:D020155), Fat (MESH:D005223), Vitamin D (MESH:D014807), lactate (MESH:D019344), isoleucine (MESH:D007532), histidine (MESH:D006639), tyrosine (MESH:D014443), leucine (MESH:D007930), valine (MESH:D014633), cholesterol (MESH:D002784), 25-hydroxy vitamin D (MESH:C104450), polyunsaturated fatty acids (MESH:D005231), 1H (-), phenylalanine (MESH:D010649), acetoacetate (MESH:C016635), fatty acids (MESH:D005227), lipid (MESH:D008055), docosahexaenoic acid (MESH:D004281), glutamine (MESH:D005973), citrate (MESH:D019343), glucose (MESH:D005947), creatinine (MESH:D003404), calcium (MESH:D002118), hydrogen-1 (MESH:D006859)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12968446/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12968446/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12968446/full.md

---
Source: https://tomesphere.com/paper/PMC12968446